Mytos specializes in developing robots that grow human cells using stem cells as input. Their platform enables scaling stem-cell derived therapies for more patients and is also used for drug discovery testing. Backed by leading investors and featuring a team of experts from diverse fields, Mytos aims to revolutionize biotechnology with cutting-edge automation and mechanical engineering.
Join Mytos, a startup backed by Y Combinator, to change an entire industry by scaling cures to patients sooner. As a high-growth stem cell scientist, you'll push the limits of automation in cell therapy manufacture and learn from a world-class team of ex-Dyson engineers and Nature-published scientists.
Mytos specializes in developing robots that grow human cells using stem cells as input. Their platform enables scaling stem-cell derived therapies for more patients and is also used for drug discovery testing. Backed by leading investors and featuring a team of experts from diverse fields, Mytos aims to revolutionize biotechnology with cutting-edge automation and mechanical engineering.